|
⚲
|
| Keyboard |
| Craig Thomas | |
|---|---|
| Firm | |
| Address | c/o Verger Capital Management LLC 751 W Fourth Street, Suite 410 Winstonsalem, NC 27101 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Full House Resorts Inc | 021-340258 | Director | 10.0 M of 10.0 M |
||
| Full House Resorts Inc | 021-305728 | Director | 100.0 M of 100.0 M |
||
| Verger Fund II LLC | 021-224257 | Executive Officer | 1,230.1 M | ||
| Audax Health Solutions Inc | 021-201987 | Director | 29.0 M of 29.1 M |
||
| Blind Creek Resources Ltd | 021-153751 | Director | 0.0 M of 0.0 M |
||
| Barkerville Gold Mines Ltd | 021-151471 | Director | 2.2 M of 2.2 M |
||
| Queensland Minerals Ltd | 021-149335 | Director | 1.3 M of 3.1 M |
||
| Verger Capital Management LLC | |||||
| Verger Capital Fund LLC | 021-224256 | Executive Officer | 2,025.5 M | 2,837.2 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2017-04-28 | Grant | 43 | $167.73 | 7,212 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2017-01-30 | Grant | 145 | $120.50 | 17,472 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-11-23 | Sell | 8,500 | $120.06 | 1,020,510 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-11-23 | Option exercise | 9,924 | $26.66 | 264,574 |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2016-11-23 | Option exercise | 9,924 | ||
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-10-28 | Grant | 167 | $105.05 | 17,543 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-07-29 | Grant | 187 | $93.79 | 17,539 |
|
Idexx Laboratories Inc /DE IDXX
Deferred Stock Unit · derivative
|
2016-05-04 | Grant | 515 | ||
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2016-05-04 | Grant | 5,902 | ||
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-04-29 | Grant | 207 | $84.35 | 17,460 |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2016-02-09 | Option exercise | 2,054 | ||
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-02-09 | Option exercise | 2,054 | $17.19 | 35,308 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-02-09 | Sell | 2,054 | $69.52 | 142,794 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2016-01-29 | Grant | 250 | $70.14 | 17,535 |
|
Idexx Laboratories Inc /DE IDXX
Non-Qualified Stock Option (right-to-buy) · derivative
|
2015-11-30 | Option exercise | 7,000 | ||
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2015-11-30 | Sell | 7,000 | $70.28 | 491,960 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2015-11-30 | Option exercise | 7,000 | $17.19 | 120,330 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2015-10-30 | Grant | 255 | $68.62 | 17,498 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2015-08-31 | Sell | 800 | $71.77 | 57,416 |
|
Idexx Laboratories Inc /DE IDXX
Common Stock
|
2015-08-18 | Sell | 2,900 | $79.41 | 230,289 |
| showing 20 of 62 most recent transactions | |||||